Wang Xin Warren 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Wang Xin Warren
SVP and Pres, Asia Pacific
Transactions
- Sale
Common Stock
2019-03-01$40.31/sh−10,000$403,056→ 84,427 total - Exercise/Conversion
Common Stock
2019-02-28+1,629→ 94,427 total - Exercise/Conversion
Deferred Stock Units
2019-02-28−1,629→ 4,888 totalExp: 2022-02-28→ Common Stock (1,629 underlying)
Footnotes (5)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F4]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.15 to $40.47, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.